Colorado BioScience Association establishes 2013 board of directors

2013CBSABoardChair DerekCole

Derek Cole, the newly appointed chairman of the Colorado BioScience Association’s board of directors. Cole also is the president of Investor Relations Advisory Solutions, with offices in Broomfield and New York.

Derek Cole, president of the Broomfield- and New York-based Investor Relations Advisory Solutions, was selected to serve as the chairman of the Colorado BioScience Association’s board of directors.

Cole, who has 22 years of experience in capital markets and corporate planning, will succeed outgoing chairperson Steve Orndorff, CEO of Broomfield-based Caelus Biosciences Inc.

Additionally, CBSA announced several newly appointed and reappointed board members. They are as follows:

Newly appointed CBSA board members include:
Brenda Fielding, executive vice president of regulatory and strategic development for Clinipace;
Scott Larson, senior vice president and legal and general counsel for Lakewood-based Terumo BCT;
Brett Lund, executive vice president, general counsel and secretary of Englewood-based Gevo; Bill Marshall, Ph.D., president, CEO, co-founder and director of Boulder-based miRagen; Chris Myatt, Ph.D., co-founder and CEO of Boulder-based MBio Diagnostics Inc.; Bob Reddy, director of global marketing for Medtronic.


The newly appointed CBSA board members (from left to right): Brenda Fielding, Scott Larson, Brett Lund, Bill Marshall, Chris Myatt and Bob Reddy.

Reappointments of CBSA board members include:
Derek Cole, president of Investor Relations Advisory Solutions; Betty Iverson, director of state government affairs for Johnson & Johnson;
Kevin Smith, president and CEO of Aurora-based CID4; Rick Silva, senior director of technology transfer for the University of Colorado-Denver; Sean Moriarty, vice president and general counsel for Fort Collins-based TOLMAR Inc.; Bruce Eaton, president and CEO of i2 Pharmaceuticals Inc.

About Alicia Wallace

Alicia Wallace is the business reporter for the Boulder Daily Camera.
This entry was posted in Bioscience, Uncategorized and tagged , , , , , , , , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

One Response to Colorado BioScience Association establishes 2013 board of directors

  1. ADB Consulting is prepared to make your simulation environment as close to the real world as possible. Using an HLA wrapper paired with a 3-D game engine, simulations can become virtual reality all the while featuring a familiar and friendly interface. For the right projects, such a set up can save lots of money by allowing users to train in a very realistic simulation.